Phase II trial of docetaxel (D) plus gefitinib (G) in elderly (≥70 years) patients with advanced stage non-small cell lung cancer (ANSCLC)

被引：0
|
作者：
Williams, C. [1 ]
Bepler, G. [1 ]
Begum, M. [1 ]
Chiappori, A. [1 ]
Arora, R. [1 ]
Haura, E. [1 ]
Antonia, S. [1 ]
Extermann, M. [1 ]
Simon, G. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7690
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [32] Gefitinib: Phase II and III results in advanced non-small cell lung cancer
    Kelly, K
    Averbuch, S
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 93 - 99
  • [33] Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer: the Canadian experience
    J. Latreille
    K.A. Gelmon
    V. Hirsh
    F. Laberge
    A.W. Maksymiuk
    F.A. Shepherd
    F. Delorme
    J. Bérille
    Investigational New Drugs, 1998, 16 : 265 - 270
  • [34] Phase II trial of docetaxel with dexamethasone premedication in patients with advanced non-small cell lung cancer:: the Canadian experience
    Latreille, J
    Gelmon, KA
    Hirsh, V
    Laberge, F
    Maksymiuk, AW
    Shepherd, FA
    Delorme, F
    Bérille, J
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (03) : 265 - 270
  • [35] Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib
    Asahina, Hajime
    Oizumi, Satoshi
    Inoue, Akira
    Kinoshita, Ichiro
    Ishida, Takashi
    Fujita, Yuka
    Sukoh, Noriaki
    Harada, Masao
    Maemondo, Makoto
    Saijo, Yasuo
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nukiwa, Toshihiro
    Nishimura, Masaharu
    ONCOLOGY, 2010, 79 (5-6) : 423 - 429
  • [36] Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer The APRONTA Trial
    Schuette, Wolfgang
    Nagel, Sylke
    von Weikersthal, Ludwig Fischer
    Pabst, Stefan
    Schumann, Christian
    Deuss, Burkhard
    Salm, Thorsten
    Roscher, Katrin
    Dickgreber, Nicolas
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) : 2090 - 2096
  • [37] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [38] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Israel, V
    Tagawa, ST
    Snyder, T
    Jeffers, S
    Raghavan, D
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (03) : 291 - 297
  • [40] Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)
    Valerie Israel
    Scott T. Tagawa
    Terry Snyder
    Susan Jeffers
    Derek Raghavan
    Investigational New Drugs, 2004, 22 : 291 - 297
12345